Webinar: Understanding the Wound Care Management (WCM) Market Landscape

Sponsored by: GlobalData

Focused on:

  • Wounds

Date: 10 August

106

Time: 3PM London

A Closer Look at the Current Trends and Future Market Dynamics

Wounds and injuries are one of the most common afflictions that affect billions worldwide. Many millions of people suffer trauma and burns as a result of accidents, natural disasters, and violence. Many more acquire chronic, hard-to-heal wounds due to complications from diabetes, obesity, and cardiovascular disease, which are projected to rise dramatically throughout the world in the coming decades. Aged populations, which are particularly prone to acquiring wounds, are growing in number, further exacerbating public health problems by driving expenditure and limiting treatment availability. Rising rates of risk factors and the need for cost-efficient treatments are driving the need of better wound care products.

Wound therapies have steadily advanced in recent decades to treat patients more effectively and comprehensively. Novel formats address all aspects of wound treatment including initial wound closure, debridement, cleansing, moisture absorption and retention, physical protection, and infection prevention and control. Standard treatments, such as dressings, topical negative pressure, and wound debridement, will continue to work hand-in-hand with advanced therapies to heal wounds completely and without complications. Advanced products, such as tissue engineered skin substitutes and biologically active dressings, will play an increasing role in wound healing in the years to come.

GlobalData Wound Care Management (WCM) market data – part of our Medical Intelligence Center platform – delivers granular WCM market data and analysis built with stakeholder surveys, demanding and supply side primary research and secondary research, covering 39 countries. The interactive forecast model and deliverables provides quantitative insight on market size trends, providing market value, market size, average selling prices, market share and distribution channel share, at a country level. For each parameter, assumptions and methodology are clearly outlined and fully sourced. Medtrics tool on our platform offers a one stop shop for analysis of the WCM data, which provides market insight that can be directly translated to tactical marketing strategies.

In this webinar, GlobalData’s Senior Analyst covering Wound Care Management, Tina Deng, will share insights pulled from GlobalData’s Market Models: Wound Care Management, 39 countries, 2005-2024. Tina will outline and review the current adoption trends, discuss unmet needs and opportunities, present a comprehensive analysis of market dynamics and competitive landscape globally. Dr. Andrew S. Thompson, GlobalData’s director covering medical devices research and analysis, will moderate a Q&A session following the presentation.

Presented by

Tina Deng,

Senior Analyst, Medical Devices

Tina Deng is a Senior Analyst in the medical devices team at GlobalData Healthcare in Toronto, where she provides strategic and market insights in the form of comprehensive market models and syndicated reports to medical devices and healthcare clients. Prior to working at GlobalData, she was a consultant at Livingston Market Consultants and performed qualitative and quantitative market research studies in China. Tina also has 3 years’ experience in medical device industry in Asia and North America, which greatly enhanced her understanding of healthcare marketing from global and regional perspectives. Tina received a B.Eng in Bioengineering and two Masters, one in Molecular Biology and the other in Biomedical Science from the University of Guelph.

Dr Andrew S. Thompson,

Director of Therapy Research and Analysis, Medical Devices

Andrew joined GlobalData in 2012, as a senior analyst, based in London, and has authored a number of MediPoint reports, focussing on molecular diagnostic tests in use within the healthcare industry. Previously, Andrew worked for over 15 years within the biotechnology industry and academia, playing a leading role in the development of in vitro diagnostic tests. Andrew received a B.S. in Applied Microbiology from Strathclyde University and a Ph.D. in Biological Sciences from the University of Warwick, UK.

Key Learning Objectives

  • Learn how GlobalData expects the WCM market landscape in the 39 countries to change over the 2017–2024 forecast period.
  • Gain insight on the unmet needs and adoption trends of different WCM devices.
  • Identify the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • Develop business strategies by understanding the trends shaping and driving the global WCM market.

Audience

  • Managers/Senior Managers/Associate Directors/Directors of Market Research
  • Business Insights
  • Market Intelligence
  • Strategic Insights
  • Forecasting
  • Pipeline Management
  • Competitive Strategy
  • Customer Insights
  • Heads of Research and Development
  • Heads of Product Planning and Marketing
  • Brand Managers